Objective: To determine the effects of interferon-gamma (IFN-γ) on bone remodeling during orthodontic tooth movement.

Materials and Methods: Thirty adult male Sprague Dawley rats were randomly categorized into five groups. IFN-γ was administered in three different doses (0.01, 0.02, and 0.05 μg/20 μL) and the remaining two groups served as control. Mandibular first molars were moved mesially by means of Ni-Ti closed coil springs in all groups. The results were evaluated histomorphometrically, and parameters of trabecular bone volume (BV/TV), trabecular bone number (Tr.N), and trabecular separation (Tr.Sep) were observed at the interradicular bone area of the mandibular first molars.

Results: Increases in BV/TV and Tr.N and decreases in Tr.Sep revealed the antiosteoclastic activity of IFN-γ.

Conclusion: IFN-γ administration may be useful clinically for anchorage control.

Orthodontic tooth movement requires remodeling of alveolar bone, and cytokines have been suggested of major importance in bone remodeling. As in other connective tissues, these effects are mediated via paracrine, autocrine, and endocrine mechanisms. The principal cytokines that have been shown to affect skeletal tissues include factors previously described as monokines or lymphokines, colony-stimulating factors, prostaglandins, and differentiation factors.1–3 The T helper 1 cytokine interferon-gamma (IFN-γ) is one of them.

Interferons were originally described in 1957 as an activity found in the supernatant of virally infected cells that directly “interfered” with viral replication.4 These proteins have been classified into two types based on structural and functional criteria and the stimuli that elicits their expression. Type I interferons are primarily induced in response to viral infection and have been categorized into two subgroups: IFN-α and IFN-β. Type II interferons, known as IFN-γ, are synthesized primarily by defined subsets of T lymphocytes and natural killer cells after activation with immune and inflammatory stimuli.5–7 

IFN-γ has multiple important functions in immunoregulation. Impaired IFN-γ production or increased IFN-γ levels were determined in various diseases, and IFN-γ has been used after organ transplantations as an immunosuppressive.7–11 Although IFN-γ inhibits osteoclast formation, it has been successfully used in the treatment of osteopetrosis.12 

The phenomenon of bone resorption is very complex and has been coordinated by cellular and hormonal factors at in vivo conditions. IFN-γ inhibits bone resorption and has an inhibitory effect on osteoclasts at the level of differentiation.11–15 IFN-γ is an important control mechanism in osteoclastogenesis.12,16–19 

Previous studies revealed that IFN-γ inhibits bone resorption stimulated by interleukin (IL)-1 and blocks collagenase production caused by parathyroid hormone, prostaglandin E2, 1.25(OH)2 vitamin D3, IL-1, tumor necrosis factor-α (TNF-α), and epidermal growth factor.20–22 On the other hand, various investigations have introduced conflicting results suggesting that IFN-γ modulates the function and activities of osteoblasts, osteoclasts, and chondrocytes, resulting in bone resorption, leukocyte function, and in defects of bone and cartilage.12,16 

The functions of IFN-γ in periodontal tissue have been investigated in several studies. The results of these investigations suggested that IFN-γ plays an important role in the regulation of periodontal tissue destruction and periodontal remodeling during orthodontic tooth movement.23,24 Although IFN-γ is well known in general medicine, a review of the literature showed that IFN-γ was not evaluated extensively in orthodontics. The purpose of this investigation was to determine the effects of IFN-γ on bone during orthodontic tooth movement.

The experiment was carried out according to the guidelines for the use of experimental animals of Gülhane Military Medical Academy. The study consisted of 30 adult male Sprague Dawley rats of approximately the same age with an average weight of 250 g. The rats were randomly categorized into five equal groups with six rats in each group. They were fed a standard pellet diet with tap water at libitum and were adapted to a 12:12-hour light:dark cycle.

The rats were anesthetized with a combination of xylazine hydrochloride (HCL) (10 mg/kg) (Alfazyne 2%, Egevet, Izmir, Turkey) and ketamin HCL (90 mg/ kg) (Alfamine 10%, Egevet, Izmir, Turkey) before the application of the springs. The same chemicals were also used as a lethal dose before sacrifice. Isoflurane inhalation anesthetic (10 mg/kg) was used before various procedures. An orthodontic force was administered to all groups. Ni-Ti closed coil springs (0.305 × 0.915 mm) exerting 80 g of reciprocal force were applied bilaterally between the mandibular first molars and incisors. A prophylactic antibiotic (Colicillin (0.1 ml/kg) (100 mg/ml Ampicillin + 250.000 IU/ml Colistin Sulphate, Egevet, Izmir, Turkey) was administered once to prevent infection that could result from trauma during application of springs. The force was measured with a gauge, and the springs were not reactivated during the experiment.

Recombinant rat IFN-γ (rRIFN-γ) (Biological Ind, Kibbutz, Beit Haemek, Israel) was dissolved in 0.9% sodium chloride (NaCl) and prepared at three different concentrations: 0.01, 0.02, and 0.05 μg/20 μL. In the first group, 0.01 μg/20 μL rRIFN-γ was administered once a day with 80 g of orthodontic force. In the second and third groups, 0.02 and 0.05 μg/20 μL rRIFN-γ were administered, respectively, with the same sequence and dose. The last two groups were evaluated as control groups. In the fourth group, 0.9% NaCl solution was administered with the same amount and prescription (20 μL/24 h).

The experimental solutions were injected into the mesiobuccal subperiosteal area adjacent to the left and right lower first molars. Only orthodontic force was administered in the fifth group. The rats were monitored during the experiment and were sacrificed on day 7 of the experiment. The mandibles were dissected out and placed in 0.1 M phosphate-buffered 2.5% glutaraldehyde solution for fixation.

Bone Histomorphometry

Histological sections were prepared according to the “Cutting-Grinding Technique.”25 The mandibles were dehydrated with increasing ethanol concentrations. After dehydration, specimens were exposed to plastic infiltration with an increasing mixture of ethanol-methyl methacrylate. The plastic-infiltrated tissue slices were placed in embedding molds, Technovit 7.200 VLC (Heraeus-Kulzer GmbH & Co KG, Hanau, Germany) was added, and final polymerization process was accomplished.

The polymerized tissue blocks were sectioned with a band saw to 100 μm thickness and transferred to a microgrinding system, and a tissue thickness of 10–20 μm was obtained. The sections were agitate in 10% H202 for 5 minutes, rinsed in water, wiped dry, and stained in toluidine blue.

All sections were evaluated with an Olympus microscope (Olympus Optical Co, Tokyo, Japan), and 4× images were transferred to a computer and the WinTAS (Trabecular Analyze System, version 1.2.9) program (Steve Paxton, University of Leeds, Leeds, UK) (Figures 1 and 2).

Figure 1.

Histological section of group 3. (A) Trabecular bone. (B) Bone resorption area. (C) Root of the first molar

Figure 1.

Histological section of group 3. (A) Trabecular bone. (B) Bone resorption area. (C) Root of the first molar

Close modal
Figure 2.

Histological section of group 5. (A) Trabecular bone. (B) Bone resorption area. (C) Root of the first molar

Figure 2.

Histological section of group 5. (A) Trabecular bone. (B) Bone resorption area. (C) Root of the first molar

Close modal

Measurements were performed in the interradicular area of the first molars (cervical, middle, and apical). Measurements were repeated two times and the mean values were calculated. All measurements and calculations were done according to the American Society for Bone and Mineral Research nomenclature and guidelines.26 Trabecular bone volume (BV/TV), trabecular bone number (Tr.N), and trabecular separation (Tr.Sep) were measured by using the software package developed for bone histomorphometry.

Statistical Method

The statistics were performed by using an SPSS 10.0 (SPSSFW, SPSS Inc, Chicago, Ill) statistical package. Descriptive statistics were shown as mean ± standard deviation (Table 1). The differences between all groups were investigated by Kruskal-Wallis test, and P values ≤.05 were evaluated as statistically significant. The differences between IFN-γ and control groups were determined by Mann-Whitney U-test. P values ≤.05 were evaluated as statistically significant.27 

Table 1. Descriptive Statistics of Trabecular Bone Volume (BV/TV), Trabecular Bone Number (Tr.N), and Trabecular Separation (Tr.Sep) for All Groups

Table 1. Descriptive Statistics of Trabecular Bone Volume (BV/TV), Trabecular Bone Number (Tr.N), and Trabecular Separation (Tr.Sep) for All Groups
Table 1. Descriptive Statistics of Trabecular Bone Volume (BV/TV), Trabecular Bone Number (Tr.N), and Trabecular Separation (Tr.Sep) for All Groups

Statistically significant differences were observed in BV/TV (P < .05) and Tr.Sep (P < .001) parameters when all groups were compared with each other (Table 2). In the comparison of the intragroup differences, any statistically significant alterations were observed in the IFN-γ and control groups (Table 3).

Table 2. Kruskal-Wallis Test of All Groupsa

Table 2. Kruskal-Wallis Test of All Groupsa
Table 2. Kruskal-Wallis Test of All Groupsa

Table 3. Comparison of Intragroup Differences for Trabecular Bone Volume (BV/TV), Trabecular Bone Number (Tr.N), and Trabecular Separation (Tr.Sep)a

Table 3. Comparison of Intragroup Differences for Trabecular Bone Volume (BV/TV), Trabecular Bone Number (Tr.N), and Trabecular Separation (Tr.Sep)a
Table 3. Comparison of Intragroup Differences for Trabecular Bone Volume (BV/TV), Trabecular Bone Number (Tr.N), and Trabecular Separation (Tr.Sep)a

In the comparison of groups 1 and 4, an increase in BV/TV and a decrease in Tr.Sep were statistically significant (P < .05), and any statistically significant difference was observed in Tr.N (P > .05). The decrease in Tr.Sep was significant (P < .001) between groups 1 and 5, whereas the differences in Tr.N and BV/TV were not significant (P > .05) (Table 4).

Table 4. Comparison of Between-Group Differences for Trabecular Bone Volume (BV/TV), Trabecular Bone Number (Tr.N), and Tra becular Separation (Tr.Sep)a

Table 4. Comparison of Between-Group Differences for Trabecular Bone Volume (BV/TV), Trabecular Bone Number (Tr.N), and Tra becular Separation (Tr.Sep)a
Table 4. Comparison of Between-Group Differences for Trabecular Bone Volume (BV/TV), Trabecular Bone Number (Tr.N), and Tra becular Separation (Tr.Sep)a

When groups 2 and 4 were compared, the increase in BV/TV and decrease in Tr.Sep were found significant (P < .05), but the change in Tr.N was not significant (P > .05). A statistically significant decrease in Tr.Sep (P < .01) was observed in the comparison of groups 2 and 5, whereas the differences in BV/TV and Tr.N were not significant (P > .05) (Table 4).

In the comparison of groups 3 and 4, the increase in BV/TV and decrease in Tr.Sep were statistically significant (P < .01 and P < .001), but the changes in Tr.N were not significant (P > .05). In the comparison of groups 3 and 5, the increase in BV/TV (P < .05) and decrease in Tr.Sep (P < .001) were significant, whereas the differences in Tr.N were not significant (P > .05) (Table 4).

The local microenvironment is central to the regulation of osteoclastic activity, and studies show that different factors may influence the rate of orthodontic tooth movement via various biomediators.1–3 Because the short cycle in female rats causes hormonal variations, our study was carried out with male rats.28,29 In previous studies, orthodontic force was exerted by closed coil springs between the molars and incisors or elastics between the first and second molars of the rat.30–33 The mechanics used for force application resulted in the creation of retention points that caused gingival inflammation.30–35 As a result, mediators that are effective in bone resorption and osteoclastic activity were excreted.36 As easy as it is designed, the application of force mechanics leads to the risk of trauma, edema, and infection. To eliminate these probabilities, one prophylactic dose of antibiotic was administered to all rats.

The absence of investigations of the local administration of IFN-γ in experimental tooth movement led us to take advantage of other studies that used systemic or local applications of the cytokine and to adjust the doses for our experiment. In the literature, intravenous (IV), intramuscular (IM), and subcutaneous (SC) administrations to obtain systemic effects and cell culture applications were found. The half life of 100 g/m2 IFN-γ was 38 minutes IV, 2.9 hours IM, and 5.9 hours SC. Accumulations and adverse effects were not observed after use of a single dose per day for 12 consecutive days. Dose-dependent inhibition of osteoclast differentiation was demonstrated previously, and the mean dose for IFN-γ in rat was 5 MU kg/d.8,11,13–15,27,37 In light of previous studies and with the aim for local administration, the dose adjustment for IFN-γ was below the systemic doses. Additionally, we intended to observe the dose-dependent effects of IFN-γ; therefore, three different doses of the cytokine were administered.

When the outcomes of the WinTAS analysis were interpreted, the increase in BV/TV was 60.79% in group 1, 61.38% in group 2, and 75.47% in group 3 when compared with the control group 4. Similarly, in the comparison of the IFN-γ groups with group 5, the increase was 51.44% in group 1, 51.99% in group 2, and 65.27% in group 3. Although all alterations in the measured parameters were not statistically significant, these findings are in accordance with the results of in vitro studies denoting the primary effect of IFN-γ over osteogenic cells and osteoblasts and a decrease in bone resorption.20–22 

In the comparison of the parameter Tr.N, the increase was 19.93% in group 1, 19.90% in group 2, and 27.69% in group 3 compared with group 4 and 21.97% in group 1, 21.94% in group 2, and 29.86% in group 3 compared with group 5. When the Tr.Sep values of IFN-γ groups were compared with control groups, the decreases in Tr.Sep were 27.11% in group 1, 27.64% in group 2, and 35.73% in group 3 compared with group 4 and 38.92% in group 1, 39.36% in group 2, and 46.14% in group 3 compared with group 5. Increases in Tr.N and decreases Tr.Sep in the IFN-γ groups reinforced the argument that IFN-γ affects the rate of bone resorption. This could be through the stimulation of the osteoblastic cells or the inhibition of osteoclastic cells.

Alhashimi et al23 investigated the effects of IFN-γ, IL-4, and IL-10 by in situ hybridization and measured the protein levels of IFN-γ by immunohistochemistry. Induction of IFN-γ at both messenger RNA and protein levels was significantly higher on the experimental side than on the contralateral control side on day 3. The signal gradually became stronger on day 7 and remained high on day 10. The authors suggested that IFN-γ may be involved in periodontium remodeling during orthodontic tooth movement because of its potential immunoregulatory roles. These results support our findings.

Saito et al38 investigated the effects of IL-1α and IL-1β, TNF-α, and IFN-γ on Prostaglandin E (PGE) and cyclic adenosine monophosphate (cAMP) production by periodontal ligament fibroblasts. They concluded that fibroblasts respond to all the cytokines with a dose- and time-related increase in the levels of PGE and cAMP. These cytokines may regulate the function of the fibroblasts in physiological remodeling of the periodontium, as well as in inflammatory reactions.

Cornish et al16 evaluated the effect of IL-18 on mature osteoclast activity and reported that IL-18 did not induce IFN-γ production by primary osteoblasts. However, IFN-γ had the opposing action to IL-18 and inhibited primary osteoblast cell proliferation. T cell–derived factors may regulate osteoclast formation and may also influence osteoblast and chondrocyte activities. These results are in contrast with our determinations.

Key Jr et al12 used IFN-γ for long-term therapy in patients with osteopetrosis and increases in bone resorption and hematopoiesis and found an improvement in leukocyte function. It seems paradoxical at first, but when the immunoregulatory function of IFN-γ is considered, the effect of IFN-γ in osteopetrosis did not conflict with our results. As is well known, in osteopetrosis an inactivation of osteoclasts and a deficiency in regular bone resorption are the points at issue. Overall, IFN-γ performed its regulation process by activating the osteoclasts and inducing the bone resorption. These results are in concordance with our observations and the conclusions of other investigations relating the immunoregulatory properties of IFN-γ.1,10,16,18 

Ukai et al24 investigated the balance between IFN-γ and IL-4–bearing cells in human inflamed gingiva by immunohistochemistry. A low ratio of IL-4–bearing cells to IFN-γ–bearing cells was involved in the destruction of periodontal tissue. These results substantiated again the reality that IFN-γ is a cytokine increasing the cellular and humoral immune response in inflammation.6,24 

The reason for bone apposition instead of resorption in this investigation was because of orthodontic tooth movement rather than infection. In the absence of infection, IFN-γ represents its primary effect as antiosteoclastic activity. The statistical increases in BV/TV and decrease in Tr.Sep between groups 3 and 5, the insignificant but important increases BV/TV and Tr.N, and the decreases in Tr.Sep parameters between the IFN-γ and control groups emphasize a dose-dependent effect of IFN-γ. The increase in dose resulted in an increase in bone apposition and osteoblastic activity or inhibition of osteoclastic activity.

  • The antiosteoclastic activity of the groups injected with IFN-γ was greater than in the control groups.

  • Our data suggest that IFN-γ is involved in bone remodeling during orthodontic tooth movement, which strongly suppresses osteoclastogenesis.

  • IFN-γ administration may be clinically useful for anchorage control.

This research was supported by Gülhane Military Medical Academy, Department of Research and Development, as a part of a PhD thesis (No. 44/2004), and the histomorphometric evaluation of the research was conducted at Çukurova University Laboratories.

1
Goldring
,
M. B.
and
S. R.
Goldring
.
Skeletal tissue response to cytokines.
Clin Orthop Relat Res
1990
.
258
:
245
278
.
2
Gurton
,
A. U.
,
E.
Akin
,
D.
Sagdic
, and
H.
Olmez
.
Effects of PGI2 and TxA2 analogs and inhibitors in orthodontic tooth movement.
Angle Orthod
2004
.
74
:
526
532
.
3
Akin
,
E.
,
A. U.
Gurton
, and
H.
Olmez
.
Effects of nitric oxide in orthodontic tooth movement in rats.
Am J Orthod Dentofacial Orthop
2004
.
126
:
608
614
.
4
Isaacs
,
A.
,
J.
Lindenmann
, and
R. C.
Valentine
.
Virus interference. II. Some properties of interferon.
Proc R Soc Lond B Biol Sci
1957
.
147
:
268
273
.
5
Farrar
,
M. A.
and
R. D.
Schreiber
.
The molecular cell biology of interferon-gamma and its receptor.
Annu Rev Immunol
1993
.
11
:
571
611
.
6
Boehm
,
U.
,
T.
Klamp
,
M.
Groot
, and
J. C.
Howard
.
Cellular responses to interferon gamma.
Annu Rev Immunol
1997
.
15
:
749
795
.
7
Thomson
,
A. W.
and
M. T.
Lotze
.
The Cytokine Handbook.
San Diego, Calif: Academic Press; 2003:567
.
8
Arky
,
R.
and
C. S.
Davidson
.
Physicians' Desk Reference.
Montvale, NJ: Thomson Healthcare; 2004:1756–1758
.
9
van den Berg
,
W. B.
Anti-cytokine therapy in chronic destructive arthritis.
Arthritis Res
2001
.
3
:
18
26
.
10
Lisignoli
,
G.
,
S.
Toneguzzi
,
F.
Grassi
,
A.
Piacentini
,
M.
Tschon
,
S.
Cristino
,
G.
Gualtieri
, and
A.
Facchini
.
Different chemokines are expressed in human arthritic bone biopsies: IFN-gamma and IL-6 differently modulate IL-8, MCP-1 and rantes production by arthritic osteoblasts.
Cytokine
2002
.
20
:
231
238
.
11
Bemiller
,
L. S.
,
D. H.
Roberts
,
K. M.
Starko
, and
J. T.
Curnutte
.
Safety and effectiveness of long-term interferon gamma therapy in patients with chronic granulomatous disease.
Blood Cells Mol Dis
1995
.
21
:
239
247
.
12
Key
Jr,
L. L.
,
R. M.
Rodriguiz
, and
S. M.
Willi
.
et al
.
Long-term treatment of osteopetrosis with recombinant human interferon gamma.
N Engl J Med
1995
.
332
:
1594
1599
.
13
Grewal
,
T. S.
,
P. G.
Genever
,
A. C.
Brabbs
,
M.
Birch
, and
M. T.
Skerry
.
Best5: a novel interferon-inducible gene expressed during bone formation.
FASEB J
2000
.
14
:
523
531
.
14
Segal
,
J. G.
,
N. C.
Lee
,
Y. L.
Tsung
,
J. A.
Norton
, and
K.
Tsung
.
The role of IFN-gamma in rejection of established tumors by IL-12: source of production and target.
Cancer Res
2002
.
62
:
4696
4703
.
15
Steinmuller
,
C.
,
G.
Franke-Ullmann
,
M. L.
Lohmann-Matthes
, and
A.
Emmendorffer
.
Local activation of nonspecific defense against a respiratory model infection by application of interferon-gamma: comparison between rat alveolar and interstitial lung macrophages.
Am J Respir Cell Mol Biol
2000
.
22
:
481
490
.
16
Cornish
,
J.
,
M. T.
Gillespie
,
K. E.
Callon
,
N. J.
Horwood
,
J. M.
Moseley
, and
I. R.
Reid
.
Interleukin-18 is a novel mitogen of osteogenic and chondrogenic cells.
Endocrinology
2003
.
144
:
1194
1201
.
17
Koide
,
M.
,
H.
Maeda
,
J. L.
Roccisana
,
N.
Kawanabe
, and
S. V.
Reddy
.
Cytokine regulation and the signaling mechanism of osteoclast inhibitory peptide-1 (OIP-1/hSca) to inhibit osteoclast formation.
J Bone Miner Res
2003
.
18
:
458
465
.
18
Mogi
,
M.
,
K.
Kinpara
,
A.
Kondo
, and
A.
Togari
.
Involvement of nitric oxide and biopterin in proinflammatory cytokine-induced apoptotic cell death in mouse osteoblastic cell line MC3T3-E1.
Biochem Pharmacol
1999
.
58
:
649
654
.
19
Ozeki
,
N.
,
M.
Mogi
,
H.
Nakamura
, and
A.
Togari
.
Differential expression of the Fas-Fas ligand system on cytokine-induced apoptotic cell death in mouse osteoblastic cells.
Arch Oral Biol
2002
.
47
:
511
517
.
20
Gowen
,
M.
and
G. R.
Mundy
.
Actions of recombinant interleukin 1, interleukin 2, and interferon-gamma on bone resorbtion in vitro.
J Immunol
1986
.
136
:
2478
2482
.
21
Gowen
,
M.
,
G. E.
Nedwin
, and
G. R.
Mundy
.
Preferential inhibition of cytokine-stimulated bone resorption by recombinant interferon gamma.
J Bone Miner Res
1986
.
1
:
469
474
.
22
Shen
,
V.
,
G.
Kohler
,
J. J.
Jeffrey
, and
W. A.
Peck
.
Bone-resorbing agents promote and interferon-gamma inhibits bone cell collagenase production.
J Bone Miner Res
1988
.
3
:
657
666
.
23
Alhashimi
,
N.
,
L.
Frithiof
,
P.
Brudvik
, and
M.
Bakhiet
.
Orthodontic movement induces high numbers of cells expressing IFN-gamma at mRNA and protein levels.
J Interferon Cytokine Res
2000
.
20
:
7
12
.
24
Ukai
,
T.
,
Y.
Mori
,
M.
Onoyama
, and
Y.
Hara
.
Immunohistological study of interferon-gamma- and interleukin-4-bearing cells in human periodontitis gingiva.
Arch Oral Biol
2001
.
46
:
901
908
.
25
Donath
,
K.
Preparation of Histologic Sections.
Norderstedt, Germany: EXAKT-Kulzer-Publication; 1995
.
26
Parfitt
,
A. M.
,
M. K.
Drezner
,
F. H.
Glorieux
,
J. A.
Kanis
,
H.
Malluche
,
P. J.
Meunier
,
S. M.
Ott
, and
R. R.
Recker
.
Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee.
J Bone Miner Res
1987
.
2
:
595
610
.
27
Zar
,
J. H.
Biostatistical Analysis.
Upper Saddle River, NJ: Prentice Hall Inc; 1996
.
28
de Vernejoul
,
M. C.
,
M.
Cohen-Solal
, and
P.
Orcel
.
Bone cytokines.
Curr Opin Rheumatol
1993
.
5
:
332
338
.
29
Haruyama
,
N.
,
K.
Igarashi
,
S.
Saeki
,
M.
Otsuka-Isoya
,
H.
Shinoda
, and
H.
Mitani
.
Estrous-cycle-dependent variation in orthodontic tooth movement.
J Dent Res
2002
.
81
:
406
410
.
30
Kvinnsland
,
S.
,
K.
Heyeraas
, and
E. S.
Ofjord
.
Effect of experimental tooth movement on periodontal and pulpal blood flow.
Eur J Orthod
1989
.
11
:
200
205
.
31
Rygh
,
P.
,
K.
Bowling
,
L.
Hovlandsdal
, and
S.
Williams
.
Activation of the vascular system: a main mediator of periodontal fiber remodeling in orthodontic tooth movement.
Am J Orthod
1986
.
89
:
453
468
.
32
Yamasaki
,
K.
The role of cyclic AMP, calcium, and prostaglandins in the induction of osteoclastic bone resorption associated with experimental tooth movement.
J Dent Res
1983
.
62
:
877
881
.
33
Yamasaki
,
K.
,
Y.
Shibasaki
, and
T.
Fukuhara
.
Behavior of mast cells in periodontal ligament associated with experimental tooth movement in rats.
J Dent Res
1982
.
61
:
1447
1450
.
34
Otero
,
R. L.
,
R. J.
Parodi
,
A. M.
Ubios
,
F. A.
Carranza
Jr
, and
R. L.
Cabrini
.
Histologic and histometric study of bone resorption after tooth movement in rats.
J Periodontal Res
1973
.
8
:
327
333
.
35
Rygh
,
P.
Ultrastructural changes in tension zones of rat molar periodontium incident to orthodontic tooth movement.
Am J Orthod
1976
.
70
:
269
281
.
36
Wennstrom
,
J. L.
,
J.
Lindhe
,
F.
Sinclair
, and
B.
Thilander
.
Some periodontal tissue reactions to orthodontic tooth movement in monkeys.
J Clin Periodontol
1987
.
14
:
121
129
.
37
Weng
,
H. L.
,
W. M.
Cai
, and
R. H.
Liu
.
Animal experiment and clinical study of effect of gamma-interferon on hepatic fibrosis.
World J Gastroenterol
2001
.
7
:
42
48
.
38
Saito
,
S.
,
P.
Ngan
,
M.
Saito
,
K.
Kim
,
R.
Lanese
,
J.
Shanfeld
, and
Z.
Davidovitch
.
Effects of cytokines on prostaglandin E and cAMP levels in human periodontal ligament fibroblasts in vitro.
Arch Oral Biol
1990
.
35
:
387
395
.

Author notes

Corresponding author: Dr Erol Akin, Gulhane Military Medical Academy, Department of Orthodontics, Gnr Dr Tevfik Saglam Cad, Ankara, Etlik 06018, Turkey. ([email protected])